Innate Pharma SA (IPHA)
1.86
-0.03
(-1.74%)
USD |
NASDAQ |
Dec 10, 13:13
Innate Pharma Market Cap: 171.45M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sanofi | 117.24B |
| DBV Technologies SA | 539.57M |
| Cellectis SA | 507.65M |
| Inventiva SA | 659.29M |
| Nanobiotix SA | 1.089B |
Market Cap Related Metrics
| PS Ratio | 24.02 |
| Price | 1.86 |
| Earnings Yield | -32.11% |